Biotech · Private company
Insud Pharma
Track this companyFree. Adds Insud Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- DrospirenonePhase 3 · ContraceptionClinicalTrials.gov · fetched Nov 12, 2026
- LPRI424 (dienogest/ethinylestradiol)Phase 3 · ContraceptionClinicalTrials.gov · fetched Nov 12, 2026
- drospirenone 4 mg oral tablet or drospirenone 3.5 mg chewable tabletChange in Bone Mineral DensityClinicalTrials.gov · fetched Nov 12, 2026
- Metronidazole GelVaginosis, BacterialClinicalTrials.gov · fetched Nov 12, 2026
- Twirla® (Levonorgestrel/Ethinyl Estradiol) Transdermal SystemResidual Drug Amount of EE and LNGClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in FemalesPHASE3 · COMPLETED · started Aug 2, 2022ClinicalTrials.gov NCT05461573 · fetched Nov 12, 2026
- LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult WomenPHASE4 · ACTIVE_NOT_RECRUITING · started Mar 28, 2022ClinicalTrials.gov NCT05303636 · fetched Nov 12, 2026
- A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal SystemPHASE4 · COMPLETED · started Oct 25, 2021ClinicalTrials.gov NCT07739589 · fetched Nov 12, 2026
- A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 CyclesPHASE3 · COMPLETED · started Dec 3, 2019ClinicalTrials.gov NCT03945513 · fetched Nov 12, 2026
- Safety and Tolerability of Metronidazole Gel 1.3%PHASE4 · COMPLETED · started Aug 12, 2015ClinicalTrials.gov NCT02392026 · fetched Nov 12, 2026